Publications by authors named "Peter Revill"

Claim this Profile
H
Hepatitis B surface antigen is upregulated by HIV Tat in an HIV-hepatitis B virus co-infection model system.
Wei Zhao, Kasha Singh, Vitini Sozzi, Paula Cevaal, Fernando J Rossello, Peter Revill

Microbiol Spectr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics and predictors of Hepatitis B surface antigen (HBsAg) loss after commencing HBV-active antiretroviral therapy (ART) in the setting of HIV-and chronic HBV co-infection.
Jennifer Audsley, Anchalee Avihingsanon, Xin Li, Rosalind Edwards, Kathy Jackson, Peter Revill

Clin Infect Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Availability of point-of-care HBV tests in resource-limited settings.
Daryl T Y Lau, Kathy Jackson, Camila A Picchio, Anna Kramvis, Mark Sonderup, Peter A Revill

Lancet Gastroenterol Hepatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR-Cas13b-mediated suppression of HBV replication and protein expression.
Laura C McCoullough, Mohamed Fareh, Wenxin Hu, Vitina Sozzi, Christina Makhlouf, Peter A Revill

J Hepatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy.
Simon J Hume, Danny K Wong, Man-Fung Yuen, Kathy Jackson, Sara Bonanzinga, Peter A Revill

Liver Int· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus.

J Gen Virol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The replication phenotype of hepatitis B virus (HBV) splice variants Sp3 and Sp9 and their impact on wild-type HBV replication.
Laura C McCoullough, Tomas Sadauskas, Vitina Sozzi, Kai Yan Mak, Hugh Mason, Peter A Revill

J Virol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathway to global elimination of hepatitis B: HBV cure is just the first step.
Jessica Howell, Chris Seaman, Jack Wallace, Yinzong Xiao, Nick Scott, Peter Revill

Hepatology· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants.
Alexander J Thompson, Kathy Jackson, Sara Bonanzinga, Sam A L Hall, Simon Hume, Peter A Revill

Hepatol Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
Peter Speck, Jason Mackenzie, Rowena A Bull, Barry Slobedman, Heidi Drummer, Peter Revill

mSphere· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
Peter Speck, Jason Mackenzie, Rowena A Bull, Barry Slobedman, Heidi Drummer, Peter Revill

mBio· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
Peter Speck, Jason Mackenzie, Rowena A Bull, Barry Slobedman, Heidi Drummer, Peter Revill

J Virol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B.
Josef Wagner, Lilly Yuen, Margaret Littlejohn, Vitina Sozzi, Kathy Jackson, Peter A Revill

Aliment Pharmacol Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: baseline hepatitis B virus haplotype number may help predict a functional cure in patients with chronic hepatitis B treated with nucleotide analogues-authors' reply.
Josef Wagner, Margaret Littlejohn, Peter A Revill

Aliment Pharmacol Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy.
Jennifer M Zerbato, Anchalee Avihingsanon, Kasha P Singh, Wei Zhao, Claire Deleage, Peter A Revill

EBioMedicine· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways.
Samuel A L Hall, Gareth S Burns, Benjamin J Mooney, Rosemary Millen, Rachel Morris, Peter A Revill

J Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook.
Anna Kramvis, Kyong-Mi Chang, Maura Dandri, Patrizia Farci, Dieter Glebe, Peter A Revill

Nat Rev Gastroenterol Hepatol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions.
Jack Wallace, Jacqueline Richmond, Jessica Howell, Behzad Hajarizadeh, Jennifer Power, Peter A Revill

Viruses· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secreted hepatitis B virus splice variants differ by HBV genotype and across phases of chronic hepatitis B infection.
Olivia Maslac, Josef Wagner, Vitina Sozzi, Hugh Mason, Jenny Svarovskaia, Peter A Revill

J Viral Hepat· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels.
Samuel A L Hall, Gareth S Burns, Despina Anagnostou, Sara Vogrin, Vijaya Sundararajan, Peter A Revill

Aliment Pharmacol Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The price tag of a potential cure for chronic hepatitis B infection: A cost threshold analysis for USA, China and Australia.
Mehlika Toy, David Hutton, Karen McCulloch, Nicole Romero, Peter A Revill

Liver Int· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A.
Hui Xu, Stephen Locarnini, Darren Wong, Rachel Hammond, Danni Colledge, Peter A Revill

J Hepatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiomes from Gambian infants reveal the development of a non-industrialized Prevotella-based trophic network.
Marcus C de Goffau, Amadou T Jallow, Chilel Sanyang, Andrew M Prentice, Niamh Meagher, Peter A Revill

Nat Microbiol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection courses, virological features and IFN-α responses of HBV genotypes in cell culture and animal models.
Min Zhang, Zhensheng Zhang, Michio Imamura, Mitsutaka Osawa, Yuji Teraoka, Peter A Revill

J Hepatol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models.
Michelle P Clark, Thao Huynh, Shringar Rao, Liana Mackiewicz, Hugh Mason, Peter Revill

Cell Death Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis